Toggle Main Menu Toggle Search

Open Access padlockePrints

Phase I study of the novel anti-cancer drug PM00104 as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors or lymphoma

Lookup NU author(s): Professor Ruth Plummer, Professor Alan Calvert


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Soria SC, Plummer R, Soto A, Massard C, Calvert H, Prados R, Angevin E, Jones C, de las Heras B

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Year of Conference: 2008

Pages: 57-57

ISSN: 1359-6349

Publisher: European Journal of Cancer Supplements: Pergamon


DOI: 10.1016/S1359-6349(08)72111-6

Notes: Poster no. 179